Brief: Torrent Pharma Says USFDA Inspected Its Bileshwarpura (Oncology) Facility From 06-Apr-26 To 10-Apr-26
April 10 (Reuters) - Torrent Pharmaceuticals Ltd TORP.NS: TORRENT PHARMA - USFDA INSPECTED OUR BILESHWARPURA (ONCOLOGY) FACILITY FROM 06-APR-26 TO 10-APR-26 TORRENT PHARMA - USFDA INSPECTION OF BILESHWARPURA FACILITY CONCLUDES WITH ZERO OBSERVATION Source text: ID:nBSE7YVnQ8 Further company coverage: TORP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says